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ABSTRACT  
Agelas sponge is found in abundancy from Indonesia’s 
ocean. This sponge produces an important chemotaxonomic group 
of compounds, derived from pyrrole-imidazole alkaloids. This group 
of compounds is one of those exclusively found from marine 
environment. Marine sponges are reported to be promising drug 
lead producers having unique chemical structures of which many 
have no terrestrial counterparts. The objective of this report is to 
give an overview of the reported attempts from up to down stream 
to develop pyrrole-imidazole alkaloids as new drug lead. Literatures 
up to 2013 reporting this group of compounds from Agelas sponges 
were studied. Discussion on the halogenated alkaloids covers the 
producers, description of high chemical diversity, identification, 
biosynthesis and ecological relevance as well as their role as a 
promising drug candidate. Alternatives to provide continous 
supplies for drug development are also discussed considering that 
wild harvesting of the sponge producers can lead to ecological 
damage in the future . Broad range of interesting pharmacological 
importance as well as several success in developing synthetic route 
for production supports its development as drug candidate.  
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INTRODUCTION 
A coverage of almost 75% of the Earth‟s 
surface has positioned the ocean as the major 
producer of natural products (Whitehead, 
1999). Unlike its terrestrial counterpart, unique 
structures has been encountered and the 
utilization has lack of ethno-medical history. 
This issue together with technical difficulties in 
collecting marine organisms held back the 
development of marine-derived natural products 
as therapeutic agents. Nevertheless, synergism 
collaboration involving pharmaceutical 
companies, academic institutions, governmental 
and so non-governmental agencies, has made a 
significant progress in form of systemic 
investigations directed towards the collection 
and characterizations of marine natural 
products, as well as the evaluation of their 
biological activity (Christian et al., 1997; 
Amador et al., 2003). Large numbers of novel 
marine-derived compounds reported in the 
literatures in the last decades exhibit the 
positive development (Mayer and Gustafson, 
2003; Amador et al., 2003). Some promising 
agents which are naturally derived or the 
synthetic derivates have entered preclinical and 
also clinical trials which can be expected that 
the number will increase in the near future 
(Amador et al., 2003).  
According to Proksch and co-workers 
(2002), the majority of marine natural products 
currently in clinical trial or under clinical 
evaluation are produced by invertebrates. The 
soft bodied, sessile or slow-moving marine 
invertebrates having lack of morphological 
defense structure in form of spines or a 
protective shell make them more vulnerable for 
predation which justifies the ecological 
importance of utilizing chemical constituents 
for surveillance in the respective invertebrates 
(Proksch et al., 2002).  
Database provided by MarinLit (2002) 
shows that the source of new marine natural 
products is dominated by sponges (37%) 
followed by coelenterates (21%). Blunt et al. in 
a review of marine natural products (2005) and 
Hu et al. (2011) supported the above mentioned 
statement. This data somehow define the role 
of marine invertebrates as a potential source of 
new drug candidates. Up to now more than 
17,000 marine products have been described 
(MarinLit, 2006) of which sponges are 
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responsible for more than 5300 different 
products (Faulkner 2000, 2001, 2002). 
Moreover, the chemical diversity of sponge 
products is remarkable, in addition to the 
unusual nucleosides, bioactive terpenes, sterols, 
cyclic peptides, alkaloids, fatty acids, peroxides, 
and amino acid derivatives (which are 
frequently halogenated) (Sipkema et al., 2005).  
Pharmaceutical interest in sponges itself 
was aroused in the early 1950s by the discovery 
of the unusual nucleosides spongothymidine 
and spongouridine in the marine sponge 
Cryptotethia crypta (Bergmann and Feeney, 1950, 
1951). These nucleosides were the basis for the 
synthesis of Ara-C, the first marine-derived 
anticancer agent, and the antiviral drug Ara-A 
(Prokch et al., 2002).  
As also found in terrestrial metabolites, 
many of marine natural products act as 
regulators of specific biological functions. 
Some of them have pharmacological activity 
due to their specific interactions with receptors 
and enzymes which are not found in their 
terestral counterpart. Marine metabolites face 
the problem that they become immediately 
diluted by large volumes of seawater of which 
requires a highly potency on a molecular basis 
and retains a relatively low solubility 
(McConnel et al., 1994). It has been repeatedly 
shown that the accumulation of toxic or 
distasteful natural product is an effective 
strategy to repel potential predators (e.g. fishes) 
or in a competition for living space (Proksch et 
al., 2002; Proksch and Ebel, 1998; Proksch, 
1999; McClintock and Baker, 2001). These 
secondary metabolites, which are produced as a 
result of evolutionary pressures to reserve or 
enhance an organisms ecological success 
(Proksch, 1999), have evolved into structurally 
diverse and usually stereo-chemically complex 
compounds with specific biological activity 
(Edrada et al., 2000) many of which belong to 
novel chemical groups solely found in marine 
environment (Carte, 1993).  
The Agelas sponges classification falls 
into phylum Porifera; class Demospongiae; 
order Agelasida; family Agelasidae and genus 
Agelas. This sponge found in abundance in 
Indonesia suggesting evolutionary fittness. 
Agelas linnaei, A. nakamurai (Hertiani et al., 2010;  
Murti, 2006; Eder et al., 1999), and A. 
nemoecinata (Pedradab, 2005) were examples of 
secondary metabolite producers from the 
Agelas collected from Indonesia sea, of which 
A. nakamurai as the most reported sponge from 
this genus (Hertiani et al., 2010; Murti, 2001, 
2006; Sapar et al., 2013; Eder et al., 1999; 
Trianto, 2005). Several other reports on this 
particular sponge are also derived from the 
neighbour sea, Papua New Guinea  (Iwagawa et 
al., 1998). Many pharmacological-interesting 
compounds found in these particular sponges 
including the marine specific halogenated 
alkaloids.   
 
Halogen containing metabolites 
Marine sponges are a rich source of 
highly halogenated compounds. They may 
function to resist feeding by fish and fouling by 
barnacles, bacteria, and fungi (Gribble, 2004). 
One of the widest group of halogenated 
alkaloids are bromine-containing alkaloids 
(Dembitsky and Tolstikov, 2003). High halogen 
concentration in sea water has a consequence 
of its contribution in the biosynthesis of some 
marine metabolites. Catalyzed by haloperoxi-
dases, halogenide anions from sea-water are 
oxidized (Hoffmann and Lindel, 2003) and 
then incorporated into organic compounds by 
specific halogenases (Van Pee, 2001). 
Enormous reactivity towards electrophilic 
halogenation reactions is probably the cause 
why heteroatom containing secondary 
metabolites such as pyrroles, indoles, phenols, 
and tyrosines are commonly found to be 
halogenated in sponges. Despite the relative 
concentrations of chloride, bromide and iodide 
ions exist in sea water (559mM, 0.86mM and 
0.45M respectively); marine organisms oxidize 
more bromide than chloride for incorporation 
into organic compounds (Faulkner, 1995). This 
may reflect the higher importance of 
bromoperoxidase (BPO) relative to chloro-
peroxidase (CPO) in marine life, and underline 
the fact that chlorine cannot be oxidized to 
active chlorine by BPO (Gribble, 1996b, 1998). 
Therefore bromide ions have greater ease to be 
oxidized and give bromonium species which 
react readily as electrophils with unsaturated 
species (Whitehead, 1999).  
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Brominated pyrroles have been isolated 
on several occasions as major constituents of 
marine sponges. Many of the simpler members 
of this class of compounds are structurally 
related as they comprise two heterocyclic rings 
linked by a linear chain (Whitehead, 1999). 
Over the last thirty years, numerous similar 
alkaloids with various structures and interesting 
biological activities have been isolated 
essentially (but not exclusively) from various 
species of Agelasidae, Hymeniacidonidae and 
Axinellidae (Williams and Faulkner, 1996).  
 
Characterization of halogenated 
alkaloids by LC/MS 
The presence of bromine and chlorine in 
a molecule can be easily distinguished from the 
molecular ion peak shown by their mass 
spectra. The molecular ions of chlorine and 
bromine-containing compounds will show 
multiple peaks due to the fact that each halogen 
exists as two isotopes. While 79Br and 81Br exist 
in relatively equal abundance, the natural 
chlorine isotopes consist of 75.77% of 35Cl and 
of 24.23% 37Cl (Smith, 2005). Thus the 
molecular ion of a chlorine-containing 
compound will have two peaks, separated by 
two mass units, in an intensity ratio of 3:1, 
while in a bromine-containing compounds 
these two peaks occur in approximately equal 
intensities. Therefore the presence of one 
bromine in a molecule e.g. in mukanadin C will 
be represented by two molecular ion peaks 
having a difference of two mass units in an 
equal height. In the meantime, the presence of 
two bromines as in midpacamide will appear as 
three molecular ion peaks having a difference 
of two mass units in an intensity ratio of 1:2:1. 
Furthermore in a compound bearing three 
bromines such as aplysamine-2, the molecular 
ion will appear as multiple peaks having two 
mass unit differences in a ratio of 1:2:2:1 
(Hertiani et al., 2009; Hertiani et al., 2010). 
The presence of fluorine and iodine, by 
contrast, is mono isotopic, having masses of 19 
and 127 amu respectively (Smith, 2005). Thus 
neither fluorine nor iodine substitution will 
cause the above phenomenon as can be 
observed in agelanesin B and agelanesin D 
(Hertiani et al., 2010). 
 
A distinct pseudomolecular ion pattern 
of brominated compounds in LC/MS is very 
important for preliminary characterization. This 
method can easily distinguish the presence of 
different brominated metabolites from sponge 
crude extracts. In LC/MS, after having the 
HPLC separation, the resulted peaks are 
detected by the UV detector and mass 
spectrometer. As more compounds can share 
the same UV pattern, the possibility of sharing 
the same molecular weight is less. In the case of 
brominated compounds, it is very rare to find 
different compounds having the same 
molecular weight with the same degree of 
bromination.  
 
Structural diversity of pyrrole-imidazole 
alkaloids  in Agelas sponges 
Pyrrole-imidazole alkaloids are 
exclusively found in marine sponges, mainly of 
the families Agelasidae, Axinellidae, and 
Halichondridae. The underlying C11N5 building 
block consists of a pyrrolyl-2-carbonyl unit 
being connected via an amide linkage to a 2-
amino-5-(3-amino) propylimidazole partial 
structure (Lindel et al., 2000a). The pyrrole-2-
carbonyl unit can be non-, mono-, or 
dibrominated in the 4- and 5- positions. 
Bromination of the pyrrole 3-position or of the 
imidazole part has not been observed 
(Hoffmann and Lindel, 2003). In some 
metabolites, the linear chain is cyclized to form 
an AB core of a pyrrolopyrazinone bicyclic 
system such as in dibromophakellin, agelastatin 
A, pala‟uamine, longamide A, and cyclooroidin 
(Figure 1) (Jacquot et al., 2004).  
A comparison of bromopyrrole 
congeners reported from Agelas nakamurai           
and Agelas linnaei reveals interesting finding 
(Figure 2). In the A. nakamurai most           
reported congeners are monobrominated 
(Hertiani et al., 2010; Murti, 2006; Uemoto et al., 
2009; Iwagawa et al., 1998) or dimers of 
monobrominated monomers (Eder et al., 1999), 
with an exception in Ageladine A (Most of A. 
linnaei metabolites, the pyrrole rings are 
dibrominated with exception of agelanesin A, 
agelanesin B and agelongine which are 
monobrominated. Another difference observed 
is that  all  metabolites of A. nakamurai found in  
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Figure 1. Example of pyrrole-imidazole compounds having a 
pyrrolopyrazinone bicyclic system (Jacquot et al., 2004). 
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Figure 2. Selected pyrrole-imidazole compounds isolated from A. linnaei (Hertiani et al., 2010) and 
A. nakamurai (Hertiani et al., 2010; Murti, 2005) and from A. nemoecinata (Pedradab, 2005) showing 
the similarities and differences in the structure of related compound. 
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this study have a free NH pyrrole while in most 
of the A. linnaei metabolites, the NH pyrrole is 
methylated. A clear example is provided by the 
presence of 4-bromo-1H-pyrrole-2-carboxylic 
acid in A. nakamurai, and its dibrominated N-
methyl pyrrole congener in A. linnaei (Hertiani 
et al., 2010). Furthermore, an analogue of the A. 
linnaei metabolite, 4-(4,5-dibromo-1-methyl-1H-
pyrrole-2-carboxamido) butanoic acid was 
previously reported from A. nakamurai as 4-
bromo-2-carboxamido-butanoic acid (Murti, 
2006). Other finding reported by Pedradab 
(2005) revealed the presence of di-brominated 
brompyrroles i.e.: Slagenin D and E, Oroidin, 
Dehydrooroidin, Cyclooroidin, and  
monobrominated derivates, i.e. Slagenin A, 
Sventrin  and Keramadine from A. nemoecinata.  
The pyrrole-imidazole compounds 
isolated from A. linnaei were comprised of high 
structural diversity, introducing some new 
functionality. A new compound related to 
midpacamide, Agelanin B displays an unusual 
3-hydroxyl-4-oxo-pentanoic acid instead of a 
hydantoin ring. Agelanin A introduces a unique 
functionality as the propylamide chain is cylized 
to form a dihydroimidazopyridinol ring. 
Despite its very rare mode of cyclization, a 
related structure was previously reported as 
dibromoagelaspongin, a phakellin related 
compound isolated from Tanzanian sponge 
Agelas sp. (Fedoreyev et al., 1989). The 
phakellins itself exhibit a unique array of 
functionality including a cyclic guanidine, a 
pyrrole carboxylic acid, a pyrrolidine, and a 
congener with potentially delicate vicinal 
diaminal stereocenters (Poullennec et al., 2002).  
More amino acid precursors may be 
involved in the structure of agelanesins and the 
mauritamides. In agelanesin, the imidazole ring 
is replaced with a halogenated tyramine. 
Taurine related compounds are encountered in 
two mauritamide A congeners, mauritamide B 
and C, along with a quite simple compound 2-
(4,5-dibromo-1-methyl-1H-pyrrole-2-
carboxamido) ethanesulfonic acid. Moreover, a 
co-occurrence of the known serotonergic agent, 
agelongine with its pyridinium ring in the 
structure to replace the imidazole nucleus and 
an ester linkage to replace the amidic bond 
(Cafieri et al., 1995) is also isolated from this A. 
linnaei sponge. 
 
Brominated pyrroles: UV spectra 
characteristics  
Databases of this group of compounds 
revealed their distinct UV spectra due to a 
shared chromophore, a pyrrole-2-carbonyl ring. 
According to Jaffe and Orchin (1962), a 
maximum absorption at around 270nm is 
detected for this particular group.  
Comparison of several pyrrole imidazole 
alkaloids showed different characteristics in 
their UV spectra (Figure 3a). Pyrrole imidazoles 
having an additional tyramine in the molecules 
experience reduced intensity of the absorption 
band at around 270 nm and have an increase of 
the absorption band at around 210nm which 
represent the additional phenolic unit (Figure 
3b).  A cyclization of the linear chain to form 
the pyrrolopyrazinone bicyclic system as can be 
observed in mukanadin C, longamide C, as well 
as in the phakellins intensifies the absorption 
band at around 230nm (Figure 3d). Agelanin A, 
on the other hand, forms a cyclization between 
N-7 and the imidazole ring which causes a 
major modification. A pronounced bathocromic 
shift of the major band to  340nm is observed 
(Figure 3a) (Hertiani et al., 2010). This kind of 
bathocromic shift can also be observed in 
hymenialdisins (Figure 3e) (Baker, 2004). 
Stevensine which differs in the imidazoline ring 
part, loses the second band and only shows a 
major peak at around 240nm, while in 2-
bromoaldisin the second band is encountered 
at around 315 nm (Pedradab, 2005). 
 
Brominated pyrroles: biosynthesis aspect 
Despite the importance on pharma-
cological activities and chemotaxonomic 
considerations (Braekman et al., 1992), 
knowledge on pyrrole-imidazole alkaloids 
biosynthesis remains in question (Travert and 
Al-Mourabit, 2004). Symbiotic microorganisms 
were suggested to play a role in the biosynthesis 
based on the fact that bromopyrole alkaloids is 
reported from an assortment of sponge        
genera. Moreover, populations of heterotrophic 
bacteria were found in Carribean sponge Agelas 
conifera,. Nevertheless, cellular localization 
studies by differential centrifugation and         
Ficoll density gradients demonstrated that 
oroidin and sceptrin were associated with 
sponge spherulous cells and not with the 
bacterial   fraction (Richelle-Maurer et al., 2003).  
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Figure 3. UV absorption pattern of several pyrrole imidazole alkaloids. 
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Several studies showed that spherulous cells, 
when present, are producers of the bioactive 
metabolites (Marin et al., 1998; Müller et al., 1986; 
Salomon et al., 2001; Thompson et al., 1983; Turon 
et al., 2000; Uriz et al., 1996; Richelle-Maurer et 
al., 2003). The production of an oroidin dimer, 
stevensine, by adding amino acid precursors 
into a sponge cells culture performed by 
Andrade et al. (1999) supports that these 
alkaloids are produced by sponge cell and not 
by symbiont (Richelle-Maurer et al., 2003). 
A shared biosynthetic pathway is 
proposed for pyrrole imidazole alkaloids based 
on a common key metabolite, oroidin (Al 
Mourabit and Potier, 2001; Hoffmann and 
Lindel, 2003). Several alternatives have been 
discussed with regard to their biosynthesis. 
While the pyrrole part is generally expected to 
be derived from proline/ornithine, different 
proposals have been put forward for the 2-
amino-5-(3-amino) propylimidazole part (Lindel 
et al., 2000a). Considering that the metabolism of 
proline in some plants and microorganisms is 
known to be stress dependent (Hare and Cress, 
1997; Ballantyne and Storey, 1983), even 
though the ecological role of proline in sponges 
is not known, its role under stress conditions is 
assumed crucial for surveillance. Thus, if proline 
is involved in C11N5 formation under oxidative 
conditions, this would be in accordance with the 
ecological role of “oroidin-based” alkaloids 
used by sponges as a chemical arsenal for their 
defense (Travert and Al-Mourabit, 2004).  
Braekman and collaborators (1992) 
proposed that proline, ornithine, and guanidine 
are probable precursors of both the 
bromopyrrole and 2-aminoimidazolinone 
moieties, based on the fact that proline and 
ornithine are two closely related amino acids of 
the glutamate group and the oxidation of 
proline into pyrrole-2-carboxylic acid is a 
general catabolic pathway (Michal, 1972). 
Saxitoxin which is an analogue of 
aminopropylimidazole has been reported to be 
arouse from ornithine (Shimizu et al., 1984). 
Other finding revealed the occurence of 
girolline with its linear or cyclized pyrrole 
derivatives in “Pseuodaxynissa” cantharella (Ahond 
et al., 1988), suggests the biosynthetic pathway 
of these alkaloids proceeds by formation of an 
amide bond between a pyrrole-2-carboxylic 
acid precursor and an amino propylimidazole 
moiety (Braekman et al., 1992). 
Hoffmann and Lindel (2003) suggested a 
different pathway of which ornithine is 
incorporated into proline, and being oxidized 
to form the pyrrole-2-carboxylic acid moiety. A 
biosynthetic experiment performed by Andrade 
and collaborators (1999) in the sponge cell 
cultures revealed that 14C-labeled proline, 
ornithine, and histidine were incorporated into 
stevensine. Natural compounds 3-amino-1-(2-
aminoimidazolyl)-prop-1-ene and 4,5-dibromo-
pyrrole carboxylic acid were proposed as 
intermediates (Andrade et al., 1999). Further-
more, Hoffman and Lindel (2003) proposed 
that if histidine is a biogenetic precursor, the 
natural product clathramide A could be a 
biogenetic intermediate in Agelas clathrodes 
(Cafieri et al., 1998a; Cafieri et al., 1996). The 
missing carbon atom would be incorporated 
into the histidine-derived portion via 
methylation of the imidazole 5-portion, 
followed by conversion of clathramide A to a 
cyclopropane and subsequent ring opening 
(Figure 4) (Hoffman and Lindel, 2003). 
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Figure 4. Plausible biosynthetic pathways 
leading to the key pyrrole-imidazole alkaloid 
(according to Hoffmann and Lindel, 2003). 
 
Travert and Al-Mourabit (2004) 
postulated that a pseudo dipeptide pyrrole-
proline-guanidine is the precursor which         
leads to the amide-connected C11N5 pyrrole  
and  2-aminoimidazolinone  sections (Figure 5).  
Halogenated Alkaloids of Agelas Sponges 
Volume 25 Issue 4 (2014) 206 
N
H
O
OH
proline
NH
O N
HN
NH2
NH
O
H2N
H2N
NH
N
H
O
OH
proline NH
O N
HN
NH2
NH
O
NH
O N
H
HN
NH
NH
ONH
O N
H
HN
N
NH2
O
Br
guanidine
dispacamide A (E)-N-(3-(2-imino-5-oxoimidazolidin-4-ylidene)propyl)-
1H-pyrrole-2-carboxamide
Br
 
 
Figure 5. Sequential pyrrole and 2-aminoimida-
zolinone sections formations (according to 
Travert and Al-Mourabit, 2004). 
 
First specific step in the pyrrole 2-
aminoimidazole biosynthesis involves proline-
based peptide synthesis, followed by an 
oxidation of the proline to pyrrole section and 
then by an oxidation rearrangement of proline-
guanidine moiety to the 2-aminoimidazolinone. 
Bio mimetic spontaneous conversion study of 
proline to 2-aminoimidazolinone derivatives 
suggested dispacamide A as the forerunner of 
oroidin. As a consequence of this proposed 
pathway, 4,5-dibromopyrrole-2-carboxylic acid 
and  2-amino-5-(3-amino)propylimidazole are 
probably exist as hydrolysis products and not 
precursors (Travert and Al-Mourabit, 2004). 
Actually, either oroidin or dispacamide A 
are good candidates as a key metabolite linking 
the amino acid precursors to the pyrrole 2-
aminoimidazole family. Moreover, both 
compounds are frequently found in sponges 
together with their closely related polycyclic 
derivatives (Travert and Al-Mourabit, 2004). 
Moreover, homoarginine derivatives 
eventually open the possibility of another 
alternative biosynthetic pathway of which 
indicates the existence of a biosynthetic 
pathway via an open chain intermediate 
(Assman et al., 1999). Hoffmann and Lindel 
(2003) proposed that hydroxylation of 
homoarginine at the -position, followed by 
oxidation and cyclization generates 2-
aminohomohistidine which then undergoes 
oxidative decarboxylation and isomerization of 
the resulting double bond, eventually forms 
oroidin (Figure 4) (Lindel et al., 2000a).       
Similar co occurence of homoarginine and          
2-amino-3-prop(en)ylimidazoles in the case            
of  the aplysinamisines I and II in Aplysina             
sp. (Rodriquez and Piña, 1993) and the          
similar    biogenesis   pathway  of   enduracididine,  
an arginine-derived amino acid which has an 
imidazoline analogue of aminohistidine in its 
structure (Horii and Kameda, 1968; Hatano, et 
al., 1984; Garcia et al., 1996; Hemscheidt et al., 
1995) support the above hypothesis (Hoffman 
and Lindel, 2003). 
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Figure 6. Four building blocks and new 
nucleophilic positions (N-1 and C-3) (Al-
Mourabit and Potier, 2001) 
 
To explain the high structure diversity of 
this compound group members,  Al Mourabit 
and Potier (2001) proposed different intra 
molecular cyclization mechanisms. Positions N-
1 and C-3 of the pyrrole part participate in 
intramolecular cyclizations (Figure 6) (Al 
Mourabit and Potier, 2001), while position C-2, 
which is the most nucleophilic in a free pyrrole 
has only rarely been quaternized (Hoffmann 
and Lindel, 2003). Among the simple 
heterocycles, free or N-methylated pyrrole 
exhibits a relatively strong nucleophicity at C-2 
which even rivals nucleophilic solvents 
(Richard et al., 1998; Mayr et al., 2003; 
Hoffmann and Lindel, 2003).  
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Figure 7. The tautomerism and ambivalent 
reactivity of 2-amino-imidazole (as decribed by 
Al-Mourabit and Potier, 2001) 
 
The 2-amino-imidazole building         
block possesses tautomeric property which          
is important for the molecular diversity               
of     pyrrole-imidazole    alkaloids   (Figure   7).  
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Each tautomer engaged in this process may act 
as an initiator of controlled chain reactions 
leading to various and complex compounds. 
The tautomerism which can exist simultaneously 
will give rise to polycyclic metabolites through 
various combinations with pyrrolic building 
blocks and diverse modes of cyclization and/or 
dimerization (Al-Mourabit and Potier, 2001).  
Based on the available theory about         
the pyrrole-imidazole alkaloids biosynthesis, it 
is more likely that hymenidin is the key building 
block in their biosynthesis in A. nakamurai 
rather than oroidin. Intermolecular cyclization 
involving the N-pyrrole and C-9 of this building 
block leads to compounds like mukanadin C 
and its new derivative longamide C.  
 
 
In the case of Seribu Islands sample, A. 
linnaei, beside its possession of more diverse 
pyrrole-imidazole alkaloids, there are no 
oroidin or dispacamide as well as homoarginine 
alkaloids present, whereas some metabolite 
functionalities is unmatch with the available 
theory. Midpacamide as the major metabolite 
together with the co-existence of mauritamides 
which exhibit relatively similar functional 
groups in the imidazole ring with a dehydro 
dispacamide A recommends a putative 
biosynthetic pathway as described in figure 8. 
This pathway may explain the relation of 
almost all A. linnaei metabolites including, 
midpacamide, mauritamides, agelanin A as well 
as the phakellins. 
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Figure 8. Proposed chemical pathway leading to several A. linnaei metabolites  
 
Halogenated Alkaloids of Agelas Sponges 
Volume 25 Issue 4 (2014) 208 
An involvement of other amino acids 
such as taurine and tyrosine may also be 
involved in the diversity of this group of 
compounds. Mauritamides and N-methyl-4,5-
dibromopyrrole taurocarboxamide biosynthesis 
may require taurine as precursor. Meanwhile, 
tyrosine may involve in the agelanesins 
biosynthesis through a brominated tyramine 
related intermediate. Bioconversion pathway of 
several bromopyrrole alkaloids remains in 
question. On the other hand, a co-existence of 
the agelongine alcoholic portion, 
pyridinebetaine A (Figure 9) in Agelas 
longissima by Cafieri et al. (1998b) may 
somehow correlate to the agelongine unusual 
structure. 
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Figure 9. Agelongine and pyridinebetaine A 
(Cafieri et al., 1998b). 
 
Halogenated pyrroles: Ecology approach 
towards pharmacology prospects 
Biosynthesis of alkaloids consumes 
valuable amino acids while efficiency should 
become a basis consideration for compounds 
production. It should be an evolutionary 
advantage for a living organism to generate a 
maximum degree of molecular diversity and 
function, on the basis of a common building 
block. It would be even better, if the building 
block itself can be part of life saving efforts. 
Oroidin is a perfect example. This compound 
has been reported as the chemical weapon of 
Agelas sponges against predation by reef fishes 
and in the same time takes part as a key 
building block of the pyrrole imidazole 
alkaloids. (Hoffmann and Lindel, 2003). The 
conservation of brominated pyrrole-imidazole 
alkaloids as natural products in the tissue of 
sponges within the genus Agelas suggests that 
these compounds have been elaborated and 
retained as part of chemical defenses (Lindel et 
al., 2000b).  From an  ecological  point of  view,  
 
the anti-predatory role of oroidin-based 
alkaloids could be their most important 
biological function (Assmann et al., 2000; 
Assmann et al., 2001). 
Lindel et al. (2000b) formulated the 
structure-activity relationship of several oroidin 
related compounds for feeding deterrent 
activity. They reported that even though the 
pyrrole ring is required for the activity, this 
alone is not sufficient. A dibrominated pyrrole 
exhibited higher activity in comparison to less 
brominated analogues. On the other hand, the 
imidazole moiety is not feeding deterrent on its 
own, but enhances the activity of the pyrrole 
ring. A methylation of the N-pyrrole, the 
oxidation state of the imidazole ring at the 4-
position and the functionalization of the 
imidazole 2-position were found to give no 
influence on activity. Removal of the imidazole 
moiety with retention of the chain resulted in 
loss of activity, except for the acid. Among the 
similar, active compounds, increasing polarity 
appeared to enhance feeding deterrence. This 
anti feeding assay also revealed an additive 
effect of the active compounds but no synergy 
was observed (Lindel et al., 2000b).   
Field assays performed by Richele-
Maurer et al. (2003) showed that concentration 
of pyrrole imidazole alkaloids, oroidin and 
sceptrin in A. conifera were unaffected by 
prolonged protection from fish predators. It is 
suggested that these compounds were 
produced possibly at the limit of effectiveness. 
Wounding induced a three- to four-fold 
increase production of both compounds and 
higher amount of these bromopyrroles exuded 
into the surrounding seawater than normal. 
This action may prevent further predation as 
well as protection against invading micro-
organisms and from fouling (Richele-Maurer et 
al., 2003). This argument is in accordance with 
the activity of oroidin and several other 
bromopyrrole alkaloids against fouling and 
bacterial infection (Tsukamoto et al., 1998). The 
strategy to enhance production of bioactive 
compounds in response to environmental 
changes would optimize fitness. Defence are 
known to be costly, while energy is needed for 
other functions such as growth and 
reproduction (Schupp et al., 1999; Richele-
Maurer et al., 2003). 
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An attempt to translate the result of the 
ecological function of the halogenated pyrroles 
reveals possible development of this compound 
group as drug lead. Based on the assumption 
that effect of calcium influx and calcium levels 
in neurons, secretory cells may be related to the 
feeding deterrence through smell and taste, 
Bickmeyer et al. (2004; 2005) performed an 
experiment to observe the effect of several 
bromopyrrole alkaloids on calcium levels in 
PC12 cells (rat phaeochromocytoma cell line). 
It was reported that unpalatable 4,5-
dibromopyrrole-2-carboxylic acid against 
predatory reef fish is not (only) transduced by 
specific membrane receptors present on 
sensory nerve cells but (additionally) has a more 
general pharmacological effect on the cellular 
calcium homeostasis (Bickmeyer et al., 2004).  
Basically, chemo-receptive cells are 
exposed to the environment, and cellular 
signalling may be modulated by substances 
interacting with the basic physiology of the cell, 
but not necessarily by binding to specific taste 
receptors (Bickmeyer et al., 2004, 2005). As the 
same mechanism may work in sensory cells of 
predatory fishes and other animals like snails 
the inhibition of Ca2+ influx into receptor cells 
may be one reason for chemoreceptive detection 
(Bickmeyer et al., 2004, 2005). In harmony with 
the ecological point of view, blockade on calcium 
entry may be pharmacologically important since 
it can induce vasorelaxation as obseved in many 
hypertension drugs (Bickmeyer et al., 2004).  
Midpacamide is the major constituent of 
the A. linnaei (1.01% of sponge dried weight) 
(Hertiani et al., 2010). It is a dibrominated 
pyrrole having a N-methylated hydantoin ring 
connected through a propylamide chain. 
According to Lindel and collaborators (2000b), 
this compound is the most potent as feeding 
deterrent in comparison to the other six pyrrole 
imidazole alkaloids tested, 4,5-dibrompyrole 
carboxamide, 4,5-dibromopyrrole-2-carboxylic 
acid, oroidin, keramadine dispacamide and 
racemic longamide A. Based on this finding 
accompanied with its predominance in the 
sponge, it is likely to assume that midpacamide 
functions as the main chemical weapon of A. 
linnaei against its predators.   
Relatively high structure diversity and 
predominance of the pyrrole-imidazole 
alkaloids in A. linnaei may be due to their 
function as chemical defense for the host 
sponge in order to provide broader spectrum of 
protection. Midpacamide, as a main feeding 
deterrent (Lindel et al., 2000b) displays moderate 
cytotoxicity against mouse lymphoma cell 
L5178Y (46.7% inhibition in 10μg/mL sample 
concentration) and only low antibacterial activity 
against B. subtilis. The role of cytotoxic activity 
as well as antimicrobial and antifouling activity 
is presumably taken by other metabolites. 
A different finding was observed in A. 
nakamurai which relies more on their diterpene 
alkaloids but not pyrrole-imidazole compounds 
for chemical defences. Considering that these 
diterpenoids play a major role in sponge 
defense may answer to the less diverse 
production of pyrrole-imidazole alkaloids in 
this sponge. Among the pyrrole-imidazole 
metabolites, 4-bromo-1H-pyrrole-2-carboxylic 
acid and hymenidin are discovered to be 
predominating.  From their structure one can 
predict that these compounds contribute in the 
feeding deterrent mechanism of the sponge 
producer, together with the other congener, 4-
bromo-1H-pyrrole-2-carboxamide.  
More literatures on the oroidin derivates 
bioactivity were reports on biofilm inhibition 
effects (Richards et al., 2008a, 2008b, 2008c, 
2008d, 2008e; Ballard et al., 200; Huigens et al., 
2007) This effect has been proposed to be in 
correlation with the sponge‟s antifouling defense 
mechanism (Hertiani, 2008). Sponges as filter-
feeder organisms need to be free of fouling in 
order to  pump  water  and nutrition. Therefore, a 
chemical defense in form of antifouling 
compounds can be one powerful strategy. 
Never-theless a research done on several 
oroidin related from A. linnaei showed no 
inhibition on biofilm formation of S. epidermidis 
by in vitro method (Hertiani, 2008). This activity 
was reported from other type of compounds 
isolated from A. nakamurai, the (-)-Ageloxime 
(Hertiani et al., 2010; Hertiani, 2008). Considering 
that biofilm associated micobes have great 
significance for public health, since they may 
cause a dramatical decrease in susceptibility 
towards antimicrobial agents (Donlan, 2001). 
Finding a potential biofilm inhibitor is 
therefore of interest in combating infection 
especially in immunesuppressed condition.  
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Agelastatins (Figure 10) is probably the 
most important pyrrole-imidazole alkaloids 
isolated from Agelas sponges. These 
compounds have a unique fused tetracyclic 
skeleton which may formally be derived from 
an open chain pyrroloaminopropylimidazole 
precursor similar in structure to oroidin 
(Whitehead, 1999). In 1998, Hong et al. 
reported the isolation of the known Agelastatin 
A together with two new alkaloids, Agelastatins 
C and D from a West Australian sponge 
Cymbastela sp. (Axinellidae). Agelastatin A was 
highly toxic to brine shrimp with LC50 of 1.7 
ppm (5.0μM) whereas Agelastatin C was much 
less toxic with LC50 of ~ 220ppm. Insecticidal 
activity of Agelastatin A was reported to be 
comparable to a commercial preparation of the 
biopesticide Bacillus thuringiensis (Hong et al., 
1998; Whitehead, 1999).  
Agelastatin A was reported to exhibit 
significant cytotoxicity towards many types of 
cancer cell lines (D‟Ambrosio et al., 1993; 1996; 
Meijer et al., 2000; Pettit et al., 2005). This 
compound inhibited tumor cell growth from 
1.5 to 16 times more potently than cisplatin, 
particularly, against human bladder, skin, colon, 
and breast carcinomas (Hale et al., 2005). 
Moreover, Agelastatin A was demonstrated to 
be very effective in down-regulating the 
expression of β-catenin and in up-regulating 
Tcf-4, an inhibitor of osteopontin (OPN) at the 
cellular level. These two effects result in 
repression of OPN and inhibition of OPN-
mediated malignant cell invasion, adhesion, and 
colony formation in vitro (Mason et al., 2008). 
Longley also highlighted the ability of this 
compound in inhibiting β-catenin, which 
controls transcription of multidrug resistance 
(Longley and Johnston, 2005). Therefore, it 
could be helpful in reducing drug resistance 
issues, possibly both as single agent as well as in 
combination therapy (Forte et al., 2009). Hale 
and collaborators reported that agelastatin A 
was also exhibited inhibition activity towards 
glycogen synthase kinase-3 β (GSK-3β), an 
enzyme responsible for the neurofibrillary 
tangles typically found in Alzheimer‟s disease, 
and as a mimetic of insulin (Hale et al., 2003). 
The Palau„amines (Figure 10) is another 
series of complex, halogen containing alkaloids 
belonging to oroidin family. These compounds 
exhibit six contiguous rings and an unbroken 
chain having eight chiral centers (Whitehead, 
1999). Palau‟amine and its 4-bromo and 4,5-
dibromo derivatives were isolated in 1998 
Kinnel et al. together with three previously 
reported ring A regioisomers (styloguanidines), 
from the sponge Stylotella aurantium. 
Palau‟amine itself was reported to display a 
remarkable range of biological activities having 
an IC50 value of less than 18 ngml-1 in the 
mixed lymphocyte reaction, and values of IC50 
of 0.1 and 0.2μg/mL-1 against P-3888 and        
A-549  cel lines, respectively (Whitehead, 1999). 
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    Figure 10. Some bioactive halogenated-pyrrole derivatives from sponges. 
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The preclinical studies of this compound are 
currently in progress for anti-fungal, anti-tumor 
and immunosuppressive agent (Kinnel et al., 
1998; Whitehead, 1999). 
Tauroacidins A and B (Figure 10), two 
novel taurine-residue-containing bromopyrrole 
alkaloids which were isolated from an 
Okinawan sponge Hymeniacidon sp. (Figure 12) 
(Kobayashi et al., 1997). Both alkaloids were 
reported to show inhibitory activity against 
EGF receptor kinase and c-erb B-2 kinase (IC50, 
20μg/mL-1 each) (Kobayashi et al., 1997). Three 
other novel taurine derived brompyrrole 
alkaloids isolated from A. linnaei, Mauritamide 
B, C and 2-(4,5-dibromo-1-methyl-1H-pyrrole-
2-carboxamido)ethanesulfonic acid (Figure 9), 
exhibited no inhibition on the protein kinases 
(Hertiani, 2007). 
Other report from Scala et al. (2010) 
exhibit the potency of bromopyrrole alkaloids 
as a potential drug lead for anti protozoa. 
Dispacamide B and spongiacidin B were 
reported as a potential antimalarial and can be 
developed as drug lead based on the result that 
these compounds showing significant activity 
with low or no toxicity towards mammalian 
cells (L6). Moreover, Scala et al. (2010) also 
described dibromopalau‟amine and longamide 
B potency as trypanocidal and antileishmanial 
agents, with narrow therapeutic windows. 
Number of bromine substitution on the pyrrole 
carbon was reported to be important for the 
antiplasmodial activity (Tasdemir et al., 2007), 
which was also observed in the activity towards 
T. brucei rhodiense and Leishmania (Scala et al., 
2010). The imidazol type ring was suggested to 
be of important for antimalarial activity (Scala et 
al., 2010). 
 
Tyrosine derived  brominated compounds  
from A. linnaei  
Other important halogen containing 
secondary metabolites from sponges are the 
brominated compounds biogenetically related 
to tyrosine (Figure 11). Although this group of 
compounds is more likely to be found in 
Verongid sponges (Hamman et al., 1993; 
Tabudravu and Jaspars, 2002), nevertheless, 
König and Wright (1993) have reported the 
isolation of bromotyrosine-derived alkaloids 
(Agelorins A and B, and 11-Epifistularin-3) 
from Agelas oroides.  
Psammaplin A, a symmetrical bromo-
tyrosine disulfide possessing oxime moieties 
isolated from Verongid sponges, was found to 
have potent cytotoxicity to P 388 cells (IC50 of 
0.3μg/mL-1). Its dimeric metabolite, bisaprasin 
was   also  occured   in   the   sponge   producer 
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(Arabshahi and Schmitz, 1987; Quiñoà and 
Crews, 1987; Rodriquez et al., 1987). The fact 
that the psammaplins have been isolated from a 
diversity of sponge “sources” and that 
brominated aromatic amino acid derivatives are 
common in marine bacteria suggest that these 
metabolites may actually be produced as a 
collaborative work between the sponge host 
and the associated microorganisms (Simmons et 
al., 2005).  
Both psammaplin A and bisaprasin were 
reported as DNA methyl transferase and 
histone deacetylase inhibitors (Pina et al., 2003). 
This is an interesting finding considering the 
potential relationship between DNA methyl 
transferase and histone deacetylase as epigenetic 
modifiers of tumor suppressor gene activity 
(Pina et al., 2003). Furthermore, psammaplin A 
has also been reported to inhibit topoisomerase 
II (Kim et al., 1999) and aminopeptidase N with 
in vitro angiogenesis suppression (Shim et al., 
2004).  
Four new brominated pyrrole derivatives 
connected to a halogenated tyramine unit were 
obtained from A. linnaei (Hertiani et al., 2010). 
Halogenated tyrosine-derived metabolites are 
actually more likely to be found in Verongid 
sponges, although they were also reported from 
several others (Constantino et al., 1994; König 
and Wright, 1993). Agelorin A and B as well as 
11-epi-fistularin-3 are other known tyrosine-
related representatives from the marine sponge 
genus Agelas (König and Wright, 1993).  
The presence of a halogenated tyramine 
moiety linked to a brominated pyrrole unit has 
never been reported before from natural 
products. Replacement of the brominated 
tyramine moiety in agelanesin A and agelanesin 
C with iodinated tyramine in agelanesin B and 
agelanesin D attract attention to this group of 
compounds.  
It is very challenging to find out why this 
Agelas sponge incorporated iodine into the 
agelanesins to substitute the bromine. Iodo-
alkaloids are known to be very rare natural 
products which are until now only isolated 
from marine organisms, (Gribble, 1996a, 
1996b, 1998, 2000; Faulkner, 1995) more 
specifically from very few algae and sponges 
(Niedleman and Geigert, 1986; Constantino et 
al., 1994). Iodide availability in sea water is far 
below other halogens such as bromide and 
chloride.  
Despite its low concentration, unlike 
chloride, all known haloperoxidases are 
effective in oxidizing iodide (Niedleman and 
Geigert, 1986). According to Constantino et al. 
(1994), biosynthesis of iodinated metabolites 
seems to be related to the capability of 
organisms to concentrate iodine from sea 
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Figure 12. Chemical structures of tyrosine-derived brominated compounds from Agelas oroides 
(König and Wright, 1993) and from A. linnaei  (agelanesin A-D) (Hertiani et al., 2010) 
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water, rather than to the presence of a specific 
peroxidase. This argument was based on the 
fact that most iodo-metabolites have been 
isolated from red algae, which are known to 
contain iodine concentrations as high as 0.5% 
of weight wt (Constantino et al., 1994). An 
iodotyrosine alkaloids sponge producer, 
Iotrochota birotulata was reported to contain 
significant amounts of iodine (0.12-1.21%), 
together with comparable quantities of bromine 
(0.16-2.66%) (Kaestner, 1967). Hence this 
supports the relationship between the presence 
of iodo- metabolites and high concentration of 
iodine in the sponge tissue (Constantino et al., 
1994). 
Another question arising from the 
agelanesins unique structure is their 
biosynthesis. As described earlier, pyrrole 
imidazole family of compounds such as oroidin 
and sceptrin are predicted to be produced by 
sponge cells and not by the associated bacteria 
(Richele-Maurer, 2003). Meanwhile Simmons 
and collaborators (2005) proposed that the 
brominated tyrosine metabolites may actually 
be derived from the biosynthetic pathway of 
microorganisms living in association with 
sponges. It is therefore more likely that in case 
of the agelanesins, the brominated pyrrole 2-
carboxylic acids are produced by the sponge 
cell at first, and further converted by associated 
bacteria to afford agelanesins.  
In addition to its unique chemical 
structure, this group of compounds also 
showed interesting bioactivity. Agelanesin A - 
D showed cytotoxicity against the mouse 
lymphoma cell line (L1578Y) with IC50 value 
4.5μg/mL; 4.8μg/mL; 9.2μg/mL; and 
7.8μg/mL respectively. In comparison to other 
brominated pyrroles isolated from A. linnaei, 
only this group of compounds shows 
pronounced cytotoxicity (Hertiani et al., 2010). 
At the same time, aplysamine-2 and 
aeroplysinin-1, obtained from Pseudoceratina 
purpurea exhibits the same activity as well. Some 
other brominated tyrosine compounds have 
also been previously reported to be cytotoxic 
such as psammaplin A and bisaprasin 
(Arabshahi and Schmitz, 1987; Quiñoà and 
Crews, 1987; Rodriquez et al., 1987). Hence it is 
suggestive that the halotyramine moiety of 
agelanesin A-D is important for the activity 
(Hertiani et al., 2010). 
Based on the IC50 values of the 
agelanesines against mouse lymphoma cell line 
(L5178Y), a possible structure activity 
relationship is suggested. Since the highest 
activity was shown by agelanesin A followed by 
agelanesin B, D and C, respectively, less 
bromination on the pyrrole ring seems to be 
important for the activity (Hertiani et al., 2010). 
This is somehow in contrast to the result of 
feeding deterrent activity reported by Lindel et 
al., 2000b, since higher degree of the 
bromination in the pyrrole ring will increase the 
activity (Lindel et al., 2000b). Meanwhile, 
different halogen atom attached to the tyramine 
unit (C-12) causes only slight difference on the 
cytotoxicity (Hertiani et al., 2010). 
 
Synthesis approach: an alternative for 
continuous supply   
One of the most important requirement 
of a natural product being developed as 
medicine or drug lead, it should be obtained by 
a continuous supply. Despite being a promising 
lead for many medicinal purposes, halogenated  
alkaloids in Agelas sponges have been 
postulated to be originated from sponge cell 
itself and not from its symbiont (Richelle-
Maurer et al., 2003). This fact has closed the 
posibility of obtaining these alkaloids through 
cultivation of the endophytes/symbionts as one 
possible alternative in obtaining marine 
metabolites with more eco-friendly approach. 
Mariculture is one approach in effort to 
provide continuous supply by cultivating 
sponge in its environment. This approach has 
advantages as cultivation can be managed in its 
natural condition and may be expected to 
produce compound of interest. Nevertheless A. 
nakamurai collected from Menjangan Island in 
different collection time, resulted different 
chemical constituents as reported by Hertiani 
and collaborators (2010) and Murti (2006). 
Another report by Eder and collaborators 
(1999) reported dimers, i.e., Sceptrin, 
Debromosceptrin, Ageliferin, Nakamuric acid 
and its methyl ester derivate.  A. nakamurai 
from Okinawa has been reported to produce 
other constituents as well as the sponge  
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collected from Papua New Guinea (Iwagawa et 
al., 1998). Eventhough the above finding can be 
due to different isolation procedures applied 
for each research groups, further evaluation 
should be done in order to define the best 
cultivation as well as isolation procedure of the 
target compounds.  
Several of promising halogenated 
alkaloids from Agelas have been successfully 
synthesized in laboratory. One interesting 
example is the Agelastatins. These natural 
products share a complicated tetracyclic core 
having four stereocenters, which is a 
synthetically challenging structure. The 
impressive biological activity, following its 
scarce availability have triggered the total 
synthesis attempts for these contriguing 
substance. Fifteen total syntheses have been 
achieved for this compound, each presenting 
different strategies (Kitagawa et al., 1983; Stien 
et al., 1999; Feldman et al., 2002; Feldman et al., 
2002; Domostoj et al., 2004; Davis and Deng, 
2005; Nicolaou et al., 2000).  
Ageladine A which is 4-(4,5-dibromo-
1H-pyrrol-2-yl)]-1H-imidazo[4,5-c]pyridin-2-
amine has been reported to be successfully 
synthesized through a 12-step total synthesis  
by using a 6π-azaelectrocyclization and a 
Suzuki−Miyaura coupling of N-Boc-pyrrole-2-
boronic acid of which a chloropyridine roles as 
key step (Meketa and Weinreb, 2006). Ageladin 
A has been reported as a potential antiangiogenic 
matrixmetalloproteinase inhibitor isolated from 
A. nakamurai (Fujita et al., 2003)  
 Eventhough (Z)-hymenialdisine [(Z)-
HMD s not derived form Agelas sponge, its 
worth to be discussed here considering its 
properties as the only pyrrole imidazole 
alkaloids being potential kinase inhibitor. As it 
showed nanomolar kinase inhibitory activity 
against pan-kinases (Meijer et al., 2000), it is 
potentially useful not only for the treatment of 
cancer, but also for neurodegenerative disorders 
as Alzheimer‟s, inflammatory pathologies, type-
2 diabetes and cancer. 
Synthetic approaches (Annoura et al., 
1995; Xu et al., 1997, Sosa et al., 2000, Portevin 
et al., 2003; Papeo et al., 2005) towards             
(Z)-HMD have beenreported to produce 
multrigrams of yield. 1-Benzoyl-2-methyl-
sulfanyl-1,5-dihydroimidazol-4-one employed 
in Papeo‟s approach was also useful in the first 
total synthesis of (Z)-axinohydantoin. Different 
series of analogues were synthesized (He et al., 
2007; Chacun-Lefevre et al., 2000; Wan et al., 
2004). Those derivatives left the main features 
of (Z)-HMD binding site in the kinase ATP 
unchanged. Efforts have been made to improve 
its selectivity and permeability (Kaiser et al., 
2007; Mangu et al., 2008; Parmentier et al., 
2009). 
Psammaplin A, is a promising anti 
cancer candidate isolated from Verongid 
sponges. This compound has close structure 
relationship with the halogenated tyrosine 
derived alkaloids from Agelas sponges. This 
compounds has been developed as a drug lead 
of which its analogue substance, NP-LAQ824 
(Remiszewski, 2003), has recently entered phase 
I clinical trials in patients with solid tumors or 
leukemia (Simmons et al., 2005). 
The susccess of producing oroidin 
derivatives by several approach (Fresneda et al., 
2001; Lindel and Hoffmann, 1997; Olofson et 
al., 1998; Sun and Chen, 2007; Ando et al., 
2006) have offer more possibility of producing 
antiprotozoal compounds which are closely 
related to this compounds as described by Scala 
et al. (2010) by a synthetic route. The synthesis 
of the oroidin itself has been reported in many 
literatures (as reviewed in Forte et al., 2009). 
The method by Richards et al. (2008e) offers a 
possibility of producing the synthetic derivates 
related to this groups of compound for 
antibiofilm activity against P. aeruginosa.   
A synthetic approach opens many doors 
for these compounds to be developed as drug 
lead. Their presence as a highly diverse group 
of compounds has offered new possibilities for 
utilization as medicinal purposes. As we know 
that marine sponge metabolites face difficulties 
to be developed as drug as it needs tremendous 
amount and a continuous supply, a possiblity of 
having these compounds syntheized in the 
laboratory is relieving.  
 
CONCLUSION 
Halogenated alkaloids are marine sponge 
specific which offers a tremendous and unique 
structure diversity. These metabolites play 
significant role for their sponge producers and 
at the same time take part in the ecological 
aspects. Many halogenated alkaloids including 
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those found in Agelas sponges exhibit 
promising activity to be developed for 
medicinal purposes. Despite being sponge-
originated-metabolites, which put big question 
mark on their continuous supply has not stop 
its development. Many efforts have resulted 
succesful production of selective metabolites 
through chemical synthesis, and many more 
analogues were created for better activity or 
bioavailability to fulfill the needs for new drug 
from the deep.  
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